Maternal Determinants of HIV-exposed and HIV-unexposed Fetal Growth, Birth Outcomes and Early Infant Growth
1 other identifier
observational
218
1 country
1
Brief Summary
The purpose of this study is to understand how differences in the nutritional status and concentration of hormones and cytokines associated with cachexia in HIV+ and HIV- pregnant women living in a semi-rural and rural region of northern Tanzania affect fetal growth, pregnancy outcomes and early infant health and development. The study hypothesis is that HIV+ women will have worse nutritional status and a greater degree of cachexia which will negatively impact fetal growth, pregnancy outcomes and early infancy health and development.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
July 18, 2012
CompletedFirst Posted
Study publicly available on registry
July 24, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2013
CompletedSeptember 27, 2013
September 1, 2013
1.2 years
July 18, 2012
September 26, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Maternal cachexia score
Up to 1 month post-partum
Secondary Outcomes (4)
Maternal anthropometric measures
Up to 1 month post-partum
Fetal growth
Up to 1 month post-partum
Pregnancy outcomes
Up to 1 month post-partum
Early infant anthropometrics
Up to 1 month post-partum
Study Arms (1)
Pregnant women and infants
HIV+ and HIV- pregnant women, HIV-exposed and HIV-unexposed infants, ARV-exposed and ARV-unexposed infants
Eligibility Criteria
HIV+ and HIV- women and their infants attending a semi-rural clinic and/or rural dispensaries for their antenatal and early infancy care in north western Tanzania
You may qualify if:
- Informed consent provided by mothers, and parental consent on behalf of their infants
- Confirmed HIV status (HIV-1, HIV-2 or HIV-Dual seropositive or HIV-seronegative)
- Estimated gestational age between 12th and 34th weeks
- Stated intention to remain in the clinic catchment area ≥6 months post-partum
- Singleton birth
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kisesa Health Centre
Kisesa, Tanzania
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joann M. McDermid, PhD, RD
Cornell University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 18, 2012
First Posted
July 24, 2012
Study Start
April 1, 2012
Primary Completion
June 1, 2013
Study Completion
July 1, 2013
Last Updated
September 27, 2013
Record last verified: 2013-09